NovaQuest Capital Management
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$1.9B
Focus Areas
6
Top Stage
Approved
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Mesoblast | $1.9B |
| Mycovia Pharmaceuticals | — |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Mesoblast | $1.9B |
| Mycovia Pharmaceuticals | — |